Delivery Order SPE2DB22D3102-SPE2DB24FL2JR
Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,751.90 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 5, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML medical supplies to the Defense Logistics Agency (DLA). The $2,340.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a medical vaccine product, to the Defense Logistics Agency (DLA). The $18,850.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML vaccine made by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,431.94 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML medical supplies to the Defense Logistics Agency (DLA). The $16,606.00 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract with DLA to provide a comprehensive range of medical products to the Department of Defense worldwide. The contract has no set-aside designation and was awarded...
- The federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,523.59, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,159.16 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. This delivery order is part of a larger indefinite delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,136.44 firm fixed-price delivery order is for the medical product "ENGERIX-B 20 MCG/ML VIALML" and has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML vaccine to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The $1,400.76 firm fixed-price delivery order contract has a completion date of December 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $1,693.70 for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical division, which is a component of the U.S. Department of Defense. The award is not associated with any set-aside designation and is a firm fixed price contract with an ultimate completion date of April...